Siemens Healthineers Forecast, price target & analysts
Siemens Healthineers Target price 2025 - Analyst rating & recommendation
Siemens Healthineers Classifications & Recommendation:
Siemens Healthineers Price Target
| Target Price | €60.96 |
| Price | €47.06 |
| Potential | 29.54% |
| Number of Estimates | 19 |
| 19 Analysts have issued a price target Siemens Healthineers 2026 . The average Siemens Healthineers target price is €60.96. This is 29.54% higher than the current stock price. The highest price target is €75.00 59.37% , the lowest is €53.00 12.62% . | |
| A rating was issued by 20 analysts: 17 Analysts recommend Siemens Healthineers to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Siemens Healthineers stock has an average upside potential 2026 of 29.54% . Most analysts recommend the Siemens Healthineers stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
17 Analysts have issued a sales forecast Siemens Healthineers 2025 . The average Siemens Healthineers sales estimate is €23.7b . This is 2.27% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €24.1b 4.33% , the lowest is €23.2b 0.14% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | €22.4b | 3.15% |
|---|---|---|
| 2025 | €23.7b | 5.83% |
| 2026 | €25.1b | 6.17% |
| 2027 | €26.7b | 6.18% |
| 2028 | €28.4b | 6.53% |
| 2029 | €30.2b | 6.24% |
17 Analysts have issued an Siemens Healthineers EBITDA forecast 2025. The average Siemens Healthineers EBITDA estimate is €4.9b . This is 1.68% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €5.4b 11.43% , the lowest is €4.5b 5.94% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | €4.5b | 13.16% |
|---|---|---|
| 2025 | €4.9b | 8.18% |
| 2026 | €5.4b | 11.16% |
| 2027 | €6.0b | 10.47% |
| 2028 | €6.6b | 10.10% |
| 2029 | €7.2b | 8.52% |
EBITDA Margin
| 2024 | 20.23% | 9.70% |
|---|---|---|
| 2025 | 20.67% | 2.20% |
| 2026 | 21.64% | 4.69% |
| 2027 | 22.52% | 4.07% |
| 2028 | 23.27% | 3.33% |
| 2029 | 23.77% | 2.15% |
10 Siemens Healthineers Analysts have issued a net profit forecast 2025. The average Siemens Healthineers net profit estimate is €2.3b . This is 10.38% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.6b 21.93% , the lowest is €2.2b 5.24% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | €2.0b | 28.89% |
|---|---|---|
| 2025 | €2.3b | 18.63% |
| 2026 | €2.7b | 17.09% |
| 2027 | €3.1b | 13.00% |
| 2028 | €3.4b | 11.01% |
| 2029 | €3.9b | 13.41% |
Net Margin
| 2024 | 8.73% | 24.95% |
|---|---|---|
| 2025 | 9.78% | 12.07% |
| 2026 | 10.79% | 10.33% |
| 2027 | 11.48% | 6.39% |
| 2028 | 11.96% | 4.18% |
| 2029 | 12.77% | 6.77% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
10 Analysts have issued a Siemens Healthineers forecast for earnings per share. The average Siemens Healthineers EPS is €2.06 . This is 10.16% higher than earnings per share in the financial year 2024. The highest EPS forecast is €2.28 21.93% , the lowest is €1.97 5.35% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | €1.74 | 28.89% |
|---|---|---|
| 2025 | €2.06 | 18.39% |
| 2026 | €2.42 | 17.48% |
| 2027 | €2.73 | 12.81% |
| 2028 | €3.03 | 10.99% |
| 2029 | €3.44 | 13.53% |
P/E ratio
| Current | 24.95 | 34.74% |
|---|---|---|
| 2025 | 22.55 | 9.62% |
| 2026 | 19.26 | 14.59% |
| 2027 | 17.04 | 11.53% |
| 2028 | 15.35 | 9.92% |
| 2029 | 13.54 | 11.79% |
Based on analysts' sales estimates for 2025, the Siemens Healthineers stock is valued at an EV/Sales of 2.81 and an P/S ratio of 2.20 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 2.88 | 13.51% |
|---|---|---|
| 2025 | 2.81 | 2.31% |
| 2026 | 2.65 | 5.81% |
| 2027 | 2.50 | 5.82% |
| 2028 | 2.34 | 6.13% |
| 2029 | 2.21 | 5.88% |
P/S ratio
| Current | 2.25 | 15.35% |
|---|---|---|
| 2025 | 2.20 | 2.21% |
| 2026 | 2.07 | 5.82% |
| 2027 | 1.95 | 5.82% |
| 2028 | 1.83 | 6.13% |
| 2029 | 1.72 | 5.88% |
Siemens Healthineers...
Current Siemens Healthineers Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
| JEFFERIES |
Buy
➜
Buy
|
Unchanged | Mar 26 2025 |
| DZ BANK |
Hold
➜
Hold
|
Unchanged | Mar 24 2025 |
| HSBC |
Buy
➜
Hold
|
Downgrade | Mar 23 2025 |
| DAY BY DAY |
Sell
➜
Buy
|
Upgrade | Mar 23 2025 |
| REDBURN ATLANTIC |
Buy
➜
Buy
|
Unchanged | Mar 21 2025 |
| METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | Feb 27 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Mar 31 2025 |
|
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Mar 26 2025 |
|
Unchanged
DZ BANK:
Hold
➜
Hold
|
Mar 24 2025 |
|
Downgrade
HSBC:
Buy
➜
Hold
|
Mar 23 2025 |
|
Upgrade
DAY BY DAY:
Sell
➜
Buy
|
Mar 23 2025 |
|
Unchanged
REDBURN ATLANTIC:
Buy
➜
Buy
|
Mar 21 2025 |
|
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
Feb 27 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
